Severance Hospital, Yonsei University Health System ( Site 0080)

Seoul 03722

2 studies enrolling now · 2 studies all time

What they study most

Lung Neoplasm Malignant, Malignant Neoplasm

Studies at this site

• A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F) — Recruiting now
• KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J) — Recruiting now